ESC 365 - Serum chloride and the response to combining loop and thiazide diuretics for acute heart failure: the ALCALOTIC study

Open Access

Serum chloride and the response to combining loop and thiazide diuretics for acute heart failure: the ALCALOTIC study

Session: Management of acute heart failure: therapeutic approaches and prognosis

Topic: Pharmacotherapy

Speaker: Doctor R. de la Espriella (Valencia, ES)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Rafael de la Espriella

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)

1 presentation

0 follower

6 more presentations in this session

Sex-based differences in heart failure management and outcomes: insights from a national cohort of over 600,000 patients

Speaker: Doctor G. Baudry (Nancy, FR)

Loop diuretic use before an acute heart failure hospitalization drives natriuretic response but not the efficacy of natriuresis-guided diuretic therapy, a prespecified analysis from the PUSH-AHF trial

Speaker: Ms L. Zonneveld (Groningen, NL)

Hypokalaemia during decongestion with hydrochlorothiazide: the CLOROTIC Trial

Speaker: Doctor P. Salamanca Bautista (Seville, ES)

Urinary sodium as a predictor of loop diuretic therapy post-hospitalization

Speaker: Doctor F. Croset (Madrid, ES)

The clinical outcome comparison of early versus conventional left atrial venting for left ventricular unloading in extracorporeal cardiopulmonary resuscitation patients

Speaker: Professor M. Kim (Seoul, KR)

Access the full session

Management of acute heart failure: therapeutic approaches and prognosis

Speakers: Doctor R. de la Espriella, Doctor G. Baudry, Ms L. Zonneveld, Doctor P. Salamanca Bautista, Doctor F. Croset...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources